Applied Therapeutics, Inc.

Submit Your Information

Company Name	Applied Therapeutics, Inc.
Stock Symbol	APLT
Status	1

On August 17, 2020, Applied Therapeutics revealed that the U.S. Food and Drug Administration had placed a partial clinical hold on the Company’s ACTION-Kids study, citing the need for additional technical information to ensure that each study participant has access to the drug’s benefits. The ACTION-Kids study is evaluating the Company’s AT-007 drug for the treatment of galactosemia.

On this news, the Company’s shares fell $3.53 per share, or 12.07%, to close at $25.71 per share on August 17, 2020.

Submit Your Information

If you suffered a loss on your Applied Therapeutics, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

First Name*

Middle Initial

Last Name*

Email*

Phone*

If representing a Corporation, Trust, Partnership or other entity, Name of Entity

If representing an Entity, Position at Entity

Mailing Address

City

State/Province

ZIP/Postal Code

Country

Are you a current or former employee of the company?

Did you purchase any shares before January 01, 1970?

Shares Purchased

Number of Shares	Buy Date	Price Per Share	Add
Purchased quantity	Purchased month Purchased day Purchased year

Shares Sold

Number of Shares	Sell Date	Price Per Share	Add
	Sold month Sold day Sold year

Additional Comments